Next Financial Group’s Regenxbio RGNX Stock Holding History

Next Financial Group’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$26K	Hold	798	–	–	﹤0.01%	1769
2021 Q3	$33K	Hold	798	–	–	﹤0.01%	1598
2021 Q2	$31K	Hold	798	–	–	﹤0.01%	1590
2021 Q1	$27K	Hold	798	–	–	﹤0.01%	1536
2020 Q4	$36K	Hold	798	–	–	﹤0.01%	1315
2020 Q3	$22K	Buy	+798	New	+$26K	﹤0.01%	1377
2020 Q2	–	Sell	-1,816	Closed	-$59K	–	1618
2020 Q1	$59K	Sell	1,816 -379	-17%	-$15.8K	0.01%	930
2019 Q4	$90K	Sell	2,195 -371	-14%	-$14.7K	0.01%	982
2019 Q3	$91K	Buy	2,566 +1,214	+90%	+$49.2K	0.01%	935
2019 Q2	$69K	Buy	+1,352	New	+$67.5K	0.01%	1057
2019 Q1	–	Sell	-665	Closed	-$28K	–	2026
2018 Q4	$28K	Buy	+665	New	+$39K	0.01%	985

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Next Financial Group's RGNX Position: Q4 2021 in Review

Next Financial Group held its Regenxbio (RGNX) position steady in Q4 2021 at 798 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #1769.

Next Financial Group first reported a position in RGNX in Q4 2018 and has held it in 11 quarters since. The position peaked at $91K in Q3 2019. 172 funds tracked by Wall St. Rank hold RGNX as of Q4 2021.

Next Financial Group held 798 shares of Regenxbio worth $26K as of Q4 2021.
Next Financial Group left its Regenxbio share count unchanged in Q4 2021.
Regenxbio made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #1769 holding.
Next Financial Group first reported a position in Regenxbio in Q4 2018 and has held it in 11 quarters since.
Next Financial Group's Regenxbio position peaked at $91K in Q3 2019.
172 funds tracked by Wall St. Rank held Regenxbio as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.